COVCovalon Technologies Ltd.

TSXV · CA · Healthcare · Medical Instruments & Supplies · covalon.com

2.300CAD-1.29%Mkt Cap: 46.26M $P/E: 46.003d ago

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$135.72BUSDP/E 43.4

EssilorLuxottica Societe anonyme

$81.53BUSDP/E 30.5

BDX

Becton, Dickinson and Company

$52.30BUSDP/E 33.2

MDLN

Medline Inc. Class A Common Stock

West Pharmaceutical Services, Inc.

$24.85BUSDP/E 45.2

DIM

Sartorius Stedim Biotech

$20.46BUSDP/E 64.5

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$14.73BUSDP/E 69.1

SOLV

Solventum Corporation Common Stock

$15.25BUSDP/E 10.9

COO

The Cooper Companies, Inc.

$14.87BUSDP/E 64.6

BAX

Baxter International Inc.

$13.62BUSD

ALGN

Align Technology, Inc.

Key Statistics

Company

Market Cap46.26M $

Enterprise Value36.09M $

Revenue (TTM)23.80M $

Gross Profit12.72M $

Net Income (TTM)1.50M $

Revenue/Share0.8652 USD

Last Price2.300 CAD

Fiscal Year EndSep 2025

MR QuarterMar 2026

Employees—

CountryCA

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)46.00

P/E (Forward)19.42

PEG—

EV/EBITDA37.87

EV/Revenue1.52

P/S1.97

P/B2.30

EPS (TTM)0.05

EPS (Forward)0.12

52W Range

1.55048% of range3.100

52W High3.100 CAD

52W Low1.550 CAD

Profitability

Gross Margin53.24%

Oper. Margin10.54%

EBITDA Margin4.00%

Profit Margin6.27%

ROE6.70%

ROA5.70%

Growth

Revenue Growth15.00%

Earnings Growth152.80%

Cash Flow & Leverage

Operating CF1.67M $

CapEx (TTM)616.85K $

FCF Margin10.32%

FCF Yield5.31%

Net Debt-10.77M $

Net Debt/EBITDA-11.30

Balance Sheet

Debt/Equity0.07

Current Ratio7.57

Quick Ratio5.71

Book Value/Sh1.014 CAD

Cash/Share0.6000 CAD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 CAD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div DateNov 4, 2025

Pay DateNov 18, 2025

Splits

Last Split1:10

Split DateJul 16, 2013

Analyst Consensus

Rating—

Target (Mean)2.900 CAD

Upside (mean)+26.1%

Target Range2.900 CAD – 2.900 CAD

# Analysts1

Ownership

Shares Out.27.62M

Float14.94M

Insiders47.16%

Institutions0.00%

Short Interest

Short Ratio1.3d

Short % Out.0.03%

Shares Short16.61K

Short (prev mo.)3.88K

Technical

SMA 502.196 (+4.7%)

SMA 2001.940 (+18.6%)

Beta0.05

S&P 52W Chg18.16%

Avg Vol (30d)6.37K

Avg Vol (10d)6.58K

Technical Indicators

RSI (14)56.1

MACD0.0477

MACD Signal0.0444

MACD Hist.+0.0033

BB Upper2.407 CAD

BB Middle2.246 CAD

BB Lower2.086 CAD

BB Width14.28%

ATR (14)0.0605 CAD

Vol Ratio (20d)0.52x